Elektrofi website screenshot

Elektrofi

Elektrofi is a Boston-based biopharmaceutical formulation technology company reinventing how biologic therapies are delivered to patients. Its Hypercon ultra-high-concentration microparticle platform and Elektroject process turn monoclonal antibodies, therapeutic proteins, and other large-molecule drugs into stable, syringe-injectable formulations suited to small-volume, at-home subcutaneous self-administration instead of intravenous infusion. The company has partnered with Eli Lilly and Janssen Biotech (Johnson & Johnson) on multi-target drug-delivery collaborations, and was acquired by Halozyme Therapeutics in November 2025. Elektrofi is a biotechnology company and does not publish a public developer API; this API Evangelist profile tracks it as a company entity within the network.

Elektrofi is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Delivery, and Biologics.

Elektrofi’s developer surface includes engineering blog and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
8.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalsDrug DeliveryBiologicsFormulation TechnologySubcutaneousLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.1/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/elektrofi: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Elektrofi Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 3

The organization behind the API

Website
Website
 About
About
 Blog
Blog

Other 1

Properties that don't map to a standard resource type

Team
Team

Source (apis.yml)

apis.yml Raw ↑ 
aid: elektrofi
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/elektrofi.png
name: Elektrofi
description: Elektrofi is a Boston-based biopharmaceutical formulation technology company reinventing how biologic therapies
  are delivered to patients. Its Hypercon ultra-high-concentration microparticle platform and Elektroject process turn monoclonal
  antibodies, therapeutic proteins, and other large-molecule drugs into stable, syringe-injectable formulations suited to
  small-volume, at-home subcutaneous self-administration instead of intravenous infusion. The company has partnered with Eli
  Lilly and Janssen Biotech (Johnson & Johnson) on multi-target drug-delivery collaborations, and was acquired by Halozyme
  Therapeutics in November 2025. Elektrofi is a biotechnology company and does not publish a public developer API; this API
  Evangelist profile tracks it as a company entity within the network.
url: https://raw.githubusercontent.com/api-evangelist/elektrofi/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- general-catalyst
x-tier: stub
x-tier-reason: portfolio-lead
x-acquired-by: halozyme
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Delivery
- Biologics
- Formulation Technology
- Subcutaneous
- Life Sciences
apis: []
common:
- type: DomainSecurity
  url: security/elektrofi-domain-security.yml
- type: Website
  url: https://www.elektrofi.com/
- type: About
  url: https://www.elektrofi.com/about
- type: Blog
  url: https://www.elektrofi.com/news
- type: Team
  url: https://www.elektrofi.com/team
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence